adenosine monophosphate has been researched along with mirabegron in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wein, AJ | 1 |
| Bengtsson, T; Bokhari, MH; Chia, LY; Dehvari, N; Evans, BA; Gao, J; Ham, S; Hutchinson, DS; Kalinovich, A; Merlin, J; Mukaida, S; Nguyen, HTM; Sato, M; Summers, RJ; Whiting, L; Wootten, D | 1 |
2 other study(ies) available for adenosine monophosphate and mirabegron
| Article | Year |
|---|---|
Re: Long-Term Treatment with the Beta-3 Adrenocepter Agonist, Mirabegron Ameliorates Detrusor Overactivity and Restores Cyclic Adenosine Monophosphate (cAMP) Levels in Obese Mice.
Topics: Acetanilides; Adenosine Monophosphate; Animals; Mice; Mice, Obese; Receptors, Adrenergic; Thiazoles | 2018 |
The metabolic effects of mirabegron are mediated primarily by β
Topics: Acetanilides; Adenosine Monophosphate; Adipocytes, Beige; Adipocytes, Brown; Adrenergic beta-3 Receptor Agonists; Animals; Cells, Cultured; CHO Cells; Cricetulus; Deoxyglucose; Gene Knockout Techniques; Glycolysis; Male; Mice; Oxygen; Thiazoles; Uncoupling Protein 1 | 2020 |